Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.31
-2.18 (-29.11%)
At close: Mar 6, 2026, 4:00 PM EST
5.29
-0.02 (-0.38%)
Pre-market: Mar 9, 2026, 5:04 AM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 16.10M | 10.68M | 7.20M | 6.68M | 6.87M | | | | | |
Medical Technology Growth | 50.73% | 48.35% | 7.75% | -2.79% | -5.90% | | | | | |
| 16.10M | 10.68M | 7.20M | 6.68M | 6.87M | | | | | |
| 50.73% | 48.35% | 7.75% | -2.79% | -5.90% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 773.00K | 891.00K | 1.84M | 1.80M | 2.71M | | | | | |
| -13.24% | -51.65% | 2.62% | -33.63% | 230.40% | | | | | |
| 3.08M | 2.44M | 230.00K | 1.49M | 2.08M | | | | | |
| 26.28% | 960.43% | -84.56% | -28.26% | -67.97% | | | | | |
United States of America (USA) | 12.25M | 7.35M | 5.13M | 3.40M | 2.09M | | | | | |
United States of America (USA) Growth | 66.60% | 43.39% | 50.99% | 62.44% | - | | | | | |
| 16.10M | 10.68M | 7.20M | 6.68M | 6.87M | | | | | |
| 50.73% | 48.35% | 7.75% | -2.79% | -5.90% | | | | | |
Source: S&P Global Market Intelligence.